Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
17.26
-0.16 (-0.92%)
Feb 11, 2026, 3:04 PM CST

SHE:300122 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
2,4982,7006,3412,6224,3081,437
Cash & Short-Term Investments
2,4982,7006,3412,6224,3081,437
Cash Growth
-23.48%-57.41%141.81%-39.13%199.68%24.98%
Accounts Receivable
12,81416,27327,05920,61412,8686,624
Other Receivables
475.810.957.88.396.879.07
Receivables
13,29016,28427,06620,62212,8746,633
Inventory
20,24622,2188,9868,0207,3853,406
Prepaid Expenses
50.028.119.73-0.595.04
Other Current Assets
29.7582.61111.37148.53185.6355.67
Total Current Assets
36,11341,29342,51431,41324,75411,537
Property, Plant & Equipment
5,9755,3715,1204,6933,5572,387
Long-Term Investments
291295295284.5239170
Goodwill
19.2819.2819.2819.2819.2819.28
Other Intangible Assets
639.79300.26317.68352.71342.8270.53
Long-Term Deferred Tax Assets
1,246928.5569.19186.08115.34124.16
Long-Term Deferred Charges
1,9321,5141,088731.97485.04402.79
Other Long-Term Assets
176.09188.44308.42322.5534.91304.82
Total Assets
46,39249,91050,23238,00430,04715,215
Accounts Payable
1,5085,42013,1429,8079,1783,084
Accrued Expenses
51.85866.781,6731,2401,090501.54
Short-Term Debt
10,31811,9022,6351,785568.862,874
Current Portion of Long-Term Debt
175.4183.8336.41---
Current Portion of Leases
-9.8110.29.810.25-
Current Income Taxes Payable
168.4880.33434.59347.7933.25323.7
Current Unearned Revenue
30.7211.8711.31---
Other Current Liabilities
632.4967.03143.8640.1799.6232.88
Total Current Liabilities
12,88518,44118,08613,23011,8716,817
Long-Term Debt
3,594347.59328.08210.64236.41-
Long-Term Leases
10.8915.4525.3127.7612.24-
Long-Term Unearned Revenue
256.34230.4228.27238.34222.2115.84
Long-Term Deferred Tax Liabilities
39.7944.3157.9660.7748.3429.88
Other Long-Term Liabilities
-----4.35
Total Liabilities
16,78619,07918,72613,76812,3906,967
Common Stock
2,3942,3942,4001,6001,6001,600
Additional Paid-In Capital
210.19-47.96207.96207.96207.96
Retained Earnings
26,72728,43729,05822,42815,8496,441
Shareholders' Equity
29,60730,83131,50624,23617,6578,249
Total Liabilities & Equity
46,39249,91050,23238,00430,04715,215
Total Debt
14,09812,3593,0352,033817.762,874
Net Cash (Debt)
-11,600-9,6583,305588.943,490-1,437
Net Cash Growth
--461.19%-83.13%--
Net Cash Per Share
-4.84-4.031.380.251.45-0.60
Filing Date Shares Outstanding
2,3942,3942,4002,4002,4002,400
Total Common Shares Outstanding
2,3942,3942,4002,4002,4002,400
Working Capital
23,22822,85224,42818,18312,8834,720
Book Value Per Share
12.2512.8813.1310.107.363.44
Tangible Book Value
28,67230,51131,16923,86417,2957,959
Tangible Book Value Per Share
11.9812.7512.999.947.213.32
Buildings
-2,6342,5221,7051,0421,014
Machinery
-3,3272,5262,0641,369904.94
Construction In Progress
-1,0061,2871,8361,825906.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.